NCT05228470 2026-01-06A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.PfizerPhase 2 Completed39 enrolled 15 charts
NCT00001379 2025-06-19Treatment and Natural History Study of Lymphomatoid GranulomatosisNational Institutes of Health Clinical Center (CC)Phase 2 Completed94 enrolled 20 charts
NCT02663297 2025-05-15Administration of T Lymphocytes for Prevention of Relapse of LymphomasUNC Lineberger Comprehensive Cancer CenterPhase 1 Active not recruiting18 enrolled 10 charts